FDA approves rapid-acting inhaled insulin for children

The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and adolescents aged 6 years and older who are living with type 1 or type 2 diabetes.

Keeping kids and canines safe together

A little over a year ago, about a dozen members of the Johns Hopkins Child Injury Prevention Network logged onto their monthly Zoom call. For those working in bustling emergency departments, the meeting is a chance to brainstorm ...

page 3 from 40